Envoy Medical (COCH) Accounts Payables (2020 - 2026)

Envoy Medical has disclosed Accounts Payables across 7 years of filings, most recently posting $1.7 million for Q1 2026.

• Accounts Payables for Q1 2026 came in at $1.7 million, up 2.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (up 2.29% YoY), and the FY2025 annual result was $2.9 million, up 76.76% from the prior year.
• Accounts Payables came in at $1.7 million for Q1 2026 at Envoy Medical, down from $2.9 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $3.4 million in Q3 2023 to a low of $658899.0 in Q1 2022.
• The 5-year median for Accounts Payables is $1.6 million (2024), against an average of $1.6 million.
• Across the five-year window, Accounts Payables soared 1455.41% in 2022 and sank 48.03% in 2024, its largest moves.
• Envoy Medical's Accounts Payables stood at $1.0 million in 2022, then jumped by 54.94% to $1.6 million in 2023, then increased by 6.31% to $1.7 million in 2024, then soared by 76.76% to $2.9 million in 2025, then tumbled by 41.78% to $1.7 million in 2026.
• The last three Accounts Payables figures came in at $1.7 million (Q1 2026), $2.9 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.